These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
203 related articles for article (PubMed ID: 7569920)
21. Immune versus natural selection: antibody aldolases with enzymic rates but broader scope. Barbas CF; Heine A; Zhong G; Hoffmann T; Gramatikova S; Björnestedt R; List B; Anderson J; Stura EA; Wilson IA; Lerner RA Science; 1997 Dec; 278(5346):2085-92. PubMed ID: 9405338 [TBL] [Abstract][Full Text] [Related]
22. Completing the circle. Schultz PG; Lerner RA Nature; 2002 Aug; 418(6897):485. PubMed ID: 12152057 [No Abstract] [Full Text] [Related]
23. Diverse structural solutions to catalysis in a family of antibodies. Gigant B; Tsumuraya T; Fujii I; Knossow M Structure; 1999 Nov; 7(11):1385-93. PubMed ID: 10574796 [TBL] [Abstract][Full Text] [Related]
24. Tech.Sight. Antibody design by man and nature. Wentworth P Science; 2002 Jun; 296(5576):2247-9. PubMed ID: 12077422 [TBL] [Abstract][Full Text] [Related]
26. Chemical selection for catalysis in combinatorial antibody libraries. Janda KD; Lo LC; Lo CH; Sim MM; Wang R; Wong CH; Lerner RA Science; 1997 Feb; 275(5302):945-8. PubMed ID: 9020070 [TBL] [Abstract][Full Text] [Related]
27. [Catalytic antibodies: generation of a new class of protein catalysts exploiting the immune system]. Fujii I Yakugaku Zasshi; 1996 Aug; 116(8):606-21. PubMed ID: 8831262 [TBL] [Abstract][Full Text] [Related]
28. Routes to catalysis: structure of a catalytic antibody and comparison with its natural counterpart. Haynes MR; Stura EA; Hilvert D; Wilson IA Science; 1994 Feb; 263(5147):646-52. PubMed ID: 8303271 [TBL] [Abstract][Full Text] [Related]
29. An antibody exo Diels-Alderase inhibitor complex at 1.95 angstrom resolution. Heine A; Stura EA; Yli-Kauhaluoma JT; Gao C; Deng Q; Beno BR; Houk KN; Janda KD; Wilson IA Science; 1998 Mar; 279(5358):1934-40. PubMed ID: 9506943 [TBL] [Abstract][Full Text] [Related]
30. Thermodynamic and structural basis for transition-state stabilization in antibody-catalyzed hydrolysis. Oda M; Ito N; Tsumuraya T; Suzuki K; Sakakura M; Fujii I J Mol Biol; 2007 May; 369(1):198-209. PubMed ID: 17428500 [TBL] [Abstract][Full Text] [Related]
31. Structural basis for a disfavored elimination reaction in catalytic antibody 1D4. Larsen NA; Heine A; Crane L; Cravatt BF; Lerner RA; Wilson IA J Mol Biol; 2001 Nov; 314(1):93-102. PubMed ID: 11724535 [TBL] [Abstract][Full Text] [Related]
32. Origins and predictions of stereoselective antibody catalysis: theoretical analysis of Diels-Alder catalysis by 39A11 and its germ-line antibody. Zhang X; Deng Q; Yoo SH; Houk KN J Org Chem; 2002 Dec; 67(25):9043-53. PubMed ID: 12467427 [TBL] [Abstract][Full Text] [Related]
35. Evolving catalysts in real time. Davis MM Science; 1996 Feb; 271(5252):1078-9. PubMed ID: 8599081 [No Abstract] [Full Text] [Related]
36. Binding and catalysis: a thermodynamic study on a catalytic antibody system. Wade H; Scanlan TS Chembiochem; 2003 Jun; 4(6):537-40. PubMed ID: 12794866 [No Abstract] [Full Text] [Related]
37. Direct selection for a catalytic mechanism from combinatorial antibody libraries. Janda KD; Lo CH; Li T; Barbas CF; Wirsching P; Lerner RA Proc Natl Acad Sci U S A; 1994 Mar; 91(7):2532-6. PubMed ID: 8146149 [TBL] [Abstract][Full Text] [Related]
38. Large rate accelerations in antibody catalysis by strategic use of haptenic charge. Thorn SN; Daniels RG; Auditor MT; Hilvert D Nature; 1995 Jan; 373(6511):228-30. PubMed ID: 7816136 [TBL] [Abstract][Full Text] [Related]
39. The chemistry of the antibody molecule. Schultz PG; Yin J; Lerner RA Angew Chem Int Ed Engl; 2002 Dec; 41(23):4427-37. PubMed ID: 12458503 [TBL] [Abstract][Full Text] [Related]
40. Antibody catalysis of the oxidation of water. Wentworth P; Jones LH; Wentworth AD; Zhu X; Larsen NA; Wilson IA; Xu X; Goddard WA; Janda KD; Eschenmoser A; Lerner RA Science; 2001 Sep; 293(5536):1806-11. PubMed ID: 11546867 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]